Background-Beyond their role as innate immune effectors, natural killer (NK) cells are emerging as important regulators of angiogenesis and vascular remodeling. Pulmonary arterial hypertension (PAH) is characterized by severe pulmonary vascular remodeling and has long been associated with immune dysfunction. Despite this association, a role for NK cells in disease pathology has not yet been described. Methods and Results-Analysis of whole blood lymphocytes and isolated NK cells from PAH patients revealed an expansion of the functionally defective CD56 Ϫ /CD16 ϩ NK subset that was not observed in patients with chronic thromboembolic pulmonary hypertension. NK cells from PAH patients also displayed decreased levels of the activating receptor NKp46 and the killer immunoglobulin-like receptors 2DL1/S1 and 3DL1, reduced secretion of the cytokine macrophage inflammatory protein-1␤, and a significant impairment in cytolytic function associated with decreased killer immunoglobulin-like receptor 3DL1 expression. Genotyping patients (nϭ222) and controls (nϭ191) for killer immunoglobulin-like receptor gene polymorphisms did not explain these observations. Rather, we show that NK cells from PAH patients exhibit increased responsiveness to transforming growth factor-␤, which specifically downregulates disease-associated killer immunoglobulin-like receptors. NK cell number and cytotoxicity were similarly decreased in the monocrotaline rat and chronic hypoxia mouse models of PAH, accompanied by reduced production of interferon-␥ in NK cells from hypoxic mice. NK cells from PAH patients also produced elevated quantities of matrix metalloproteinase 9, consistent with a capacity to influence vascular remodeling. Conclusions-Our work is the first to identify an impairment of NK cells in PAH and suggests a novel and substantive role for innate immunity in the pathobiology of this disease. (Circulation. 2012;126:1099-1109.)
P ulmonary arterial hypertension (PAH) is characterized by a loss of pulmonary vasculature at the level of the precapillary arterioles. This pathological vascular remodeling is marked by excessive muscularization of the remaining pulmonary arteries and the formation of obstructive vascular lesions associated with the aberrant proliferation of endothelial cells, vascular smooth muscle cells, and fibroblasts. The resulting elevation of pulmonary arterial pressure leads to right ventricular hypertrophy and death from right heart failure. Recently, members of the transforming growth factor-␤ (TGF-␤) superfamily have been recognized as critical mediators of pulmonary vascular remodeling. Mutations in the gene encoding the bone morphogenetic protein type II receptor account for Ͼ70% of heritable PAH cases and 15% to 40% of cases of the sporadic form of the disease. 1 Reduced bone morphogenetic protein signaling and heightened TGF-␤ signaling have been reported in pulmonary vascular cells from PAH patients, whether or not a mutation is present, and in animal models of disease, as well. 2, 3 immune dysfunction, both in the setting of autoimmune disease and viral infection. For example, the prevalence of PAH is Ͼ300-fold higher in the HIV patient population (0.46%) than in the general population. 4, 5 Despite this link, there is limited understanding of the precise nature of altered immunity in PAH and how it might lead to vascular remodeling. Many studies have focused on circulating cytokines 6 or elements of the adaptive immune system in animal models of PAH. 7 In comparison, the contribution of innate immunity, and specifically the potential role of innate lymphocytes such as natural killer (NK) cells, has received considerably less attention.
NK cells are best known for their capacity to target and eliminate stressed, virally infected or oncogene-transformed cells independent of specific antigen recognition. However, a growing body of literature supports a role for NK cells in a wide array of physiological processes, including the regulation of vascular remodeling and regeneration. 8 -10 Much of this work has centered on the critical role for decidual NK (dNK) cells in the remodeling of spiral arteries at the maternal-fetal interface. During the first trimester of pregnancy, the spiral arteries are transformed from narrow, highly muscularized vessels into amuscular, trophoblast-lined channels that lack vasomotor responsiveness. 11 The importance of NK cells in this process is supported by studies demonstrating an association between preeclampsia, a disease of inadequate spiral artery remodeling, and the interaction of certain members of the killer immunoglobulin-like receptor (KIR) family with their class I major histocompatibility complex (MHC-I) ligands. 12 In PAH, recent work in the monocrotaline rat model of disease has also implicated a role for NK cells in the mode of action of experimental, cell-based therapies. 13 However, it is hitherto unknown whether an abnormal NK cell phenotype exists in patients with idiopathic or heritable PAH.
Natural killer cells also feature in the pathogenesis of HIV, where several studies have reported an altered NK cell phenotype and reduced function. HIV-seropositive individuals exhibit altered proportions of the CD56 bright /CD16 Ϫ and CD56 dim /CD16 ϩ NK cell subsets, related to a rise in circulating levels of functionally deficient, CD56 Ϫ /CD16 ϩ NK cells. 14 NK cells from HIV patients also exhibit decreased surface expression of activating receptors and altered inhibitory receptor expression, corresponding to an impaired capacity to lyse both tumor cell lines and HIV-infected autologous target cells. 14, 15 Considering the association between PAH and HIV, we sought to determine whether similar defects were present in circulating NK cells from idiopathic and heritable PAH patients. We performed a phenotypic and functional evaluation of NK cells from PAH patients and demonstrated marked differences in the absolute levels of circulating NK cell subsets, decreased surface expression of both activating and inhibitory receptors, a substantial impairment of functional capacity, and elevated production of extracellular matrixdegrading enzymes. This dysfunction does not appear to be directly linked to genetic predisposition in the patient population, but, instead, it may arise from altered TGF-␤ signaling. In the monocrotaline rat and chronic hypoxic mouse models of PAH, we were able to confirm defects in NK cell number and function that mirrored those found in human disease.
Methods

Patient Selection
Flow cytometric analysis of whole blood lymphocytes was performed on 11 PAH patients, 9 patients with chronic thromboembolic pulmonary hypertension (CTEPH), and 37 healthy donors (onlineonly Data Supplement Table I ). PAH and CTEPH cohorts were matched for hemodynamic parameters. Analysis of magnetically isolated NK cells was performed on peripheral blood samples from 14 PAH patients, 4 of whom have identified mutations in the gene for bone morphogenetic protein type II receptor, and 15 healthy donors with an equivalent distribution of age, sex, and ethnicity (online-only Data Supplement Table II ). All subjects gave informed consent to participate in the study, which was approved by the institutional ethical review committee.
Characterization of Whole Blood Lymphocytes and Magnetically Isolated NK Cells
Whole blood lymphocytes were analyzed by flow cytometry as described previously. 16 Peripheral blood mononuclear cells were isolated from whole blood by density gradient centrifugation by using Ficoll Paque Plus (GE Healthcare, NJ) and enriched for NK cells by negative magnetic selection using the EasySep NK cell enrichment kit (StemCell Technologies) according to the manufacturers' instructions. Freshly isolated NK cells were characterized with the use of the antibodies listed in the online-only Data Supplement Methods.
Human CD107a Mobilization Assay
NK cells (5ϫ10 4 cells/well) were cultured with or without K562 target cells at a ratio of 1:1 in round-bottom 96-well plates in the presence of 5 L of PE-Cy5-conjugated ␣-CD107a antibody (clone H4A3, BD Biosciences, NJ). After 1 hour, 6 g/mL monensin (GolgiStop, BD Biosciences) was added to each well, and the cultures were continued for an additional 4 hours. Following coculture, cells were washed and stained with ␣-CD56-APC, ␣-CD16-FITC, and ␣-KIR3DL1-PE (all BD Biosciences) or ␣-KIR2DL1/ S1-PE (Beckman Coulter, CA) before analysis.
Human NK Cell Culture and Gene Expression
NK cells (2ϫ10 5 cells/well) were maintained in 0.2 mL RPMI 1640 media with L-glutamine, 10% fetal bovine serum, and 0.5 U/mL penicillin-streptomycin in round-bottom 96-well plates, with or without 10 ng/mL of recombinant human TGF-␤ (R&D Systems, MN) for 72 hours, followed by staining with ␣-CD56-APC, ␣-CD16-FITC, and PE-conjugated antibodies for KIR3DL1, KIR2DL1/S1, or KIR2DL2/3 (Beckman Coulter). For gene expression, RNA was obtained from 6ϫ10 5 NK cells after 24 hours of culture and purified by using RNeasy RNA isolation columns (Qiagen, MD). The expression of plasminogen activator inhibitor-1 (PAI-1) and urokinase plasminogen activator (uPA) were determined relative to the hypoxanthine phosphoribosyltransferase (HPRT) reference gene by real-time polymerase chain reaction by the use of Qiagen QuantiTect primer assays.
Statistical Analysis
All data are presented as meanϮSEM, and a threshold of Pϭ0.05 was used for declaring statistical significance. Unpaired, 2-sided Student t tests were used for comparisons between 2 groups. Paired, 2-sided t tests were used for the analysis of within-person comparisons. For the analysis of genotype frequency data, a Bonferroni correction was used to account for multiple independent comparisons between 2 groups. Comparisons between multiple groups were assessed by ANOVA, followed by a Dunnett post hoc analysis. Statistical analysis was performed by using Prism software (Graph-Pad Software Inc, CA). We acknowledge that many of the analyses in the current study involve the comparison of small group sizes and that this factor limits our power to detect differences between groups.
For additional methods please see the online-only Data Supplement. All primers used for genotyping studies are listed in onlineonly Data Supplement Table III .
Results
Circulating CD56 dim /CD16 ؉ NK Cells Are Decreased in PAH Patients
Circulating NK cells can be divided into 2 main subsets, CD56 dim /CD16 ϩ cells, which contain all the necessary cellular machinery for cytotoxicity, and CD56 bright /CD16 Ϫ cells, which have little to no cytotoxic capacity, but produce large quantities of inflammatory cytokines on stimulation. 17 As an initial screen, freshly isolated peripheral blood mononuclear cells were stained for CD56 and CD3 and analyzed by flow cytometry ( Figure 1A through 1C ). As previously reported for HIV, the absolute number of circulating CD56 dim /CD3 Ϫ NK cells was significantly decreased in PAH patients in comparison with healthy donors ( Figure 1B) . Samples from CTEPH patients, hemodynamically matched to the PAH cohort (online-only Data Supplement Table I) , demonstrated no significant difference in the absolute number of CD56 dim / CD3 Ϫ cells in comparison with healthy controls. No differences in the number of circulating CD56 bright /CD3 Ϫ NK cells were observed between the groups ( Figure 1C ).
Previous reports have attributed the decrease in CD56 dim NK cells in HIV patients to a rise of CD56 Ϫ /CD16 ϩ NK cells in the circulation, a subset that is linked to impaired NK cell function. 14 
Analysis of Activating and Inhibitory Receptors on Isolated NK Cells
The ability of NK cells to lyse potential targets is determined through the integration of opposing signals from activating and inhibitory receptors that recognize ligands on the target cell surface. Magnetically isolated NK cells from PAH patients and healthy donors were analyzed for a panel of activating receptors, including DNAM-1, NKG2D, and the natural cytotoxicity receptors NKp46 and NKp30 ( Figure  2A ). The surface expression of NKp46 was significantly decreased on NK cells from PAH patients in comparison with controls. No significant differences were observed in surface expression of DNAM-1, NKp30, or NKG2D.
Isolated NK cells were also assessed for surface expression of activating and inhibitory KIRs ( Figure 2B and 2C). NK cells from PAH patients exhibited a decreased percentage of cells that bound the EB6B monoclonal antibody, which recognizes both the inhibitory KIR2DL1 and activating KIR2DS1 receptors. In contrast, binding of the GL183 antibody, which recognizes the KIR2DL2 and KIR2DL3 inhibitory receptors and the activating KIR2DS2, was observed at similar levels on NK cells from both PAH patients and healthy donors. Analysis of the inhibitory receptor KIR3DL1 revealed dramatic decreases in both the percentage of KIR3DL1 ϩ cells and the mean surface expression of this receptor on NK cells from PAH patients ( Figure 2C ).
NK Cells From PAH Patients Are Functionally Impaired
Recent reports have implicated a role for inhibitory, MHC-I-binding receptors, including members of the KIR family, in the education of NK cells and the enhancement of their killing capacity. 18 Having demonstrated decreased expression of certain KIRs in association with PAH, NK cell function was assessed by measuring degranulation via ␣-CD107a antibody uptake in the presence or absence of the MHC-Ideficient, K562 target cell line ( Figure 3A ). Analysis of total CD107a ϩ NK cells demonstrated a significant decrease in the overall functional capacity of circulating NK cells from PAH patients in comparison with healthy donors ( Figure 3B ).
Staining of NK cells for KIR3DL1 or KIR2DL1/S1 after coculture allowed for a determination of the contribution of these KIR ϩ subsets to the total lytic response of the entire NK cell population. To control for differences in MHC-I type between individuals, all subjects were genotyped and only those expressing the appropriate human leukocyte antigen (HLA) ligand for each KIR (HLA-Bw4 for KIR3DL1 and HLA-C2 for KIR2DL1/S1) were included in subsequent analyses. Division of CD107a positivity into relative contributions from the KIR3DL1-positive and -negative popula-tions demonstrated that, in healthy individuals expressing the HLA-Bw4 ligand, expression of the inhibitory KIR3DL1 on a particular NK cell results in an increased propensity of that cell to degranulate when cultured with target cells ( Figure  3C ). In HLA-Bw4 ϩ PAH patients, expression of KIR3DL1 provided no such enhancement of functional capacity, suggesting that decreased KIR3DL1 expression is responsible for at least part of the impaired functional capacity of NK cells in these individuals. In the case of KIR2DL1 and 2DS1, expression of at least one of these receptors, as indicated by binding of the EB6B antibody, did not result in enhanced lytic activity in either group ( Figure 3D ). However, this result may be attributable to the lack of specificity of the EB6B antibody.
Cytokine secretion in response to K562 cell stimulation, as measured by macrophage inflammatory protein-1␤ production, was also significantly decreased in NK cells from PAH patients in comparison with cells from healthy donors ( Figure  3E ), further confirming the functional impairment of these cells in PAH. Parallel cultures containing NK or K562 cells alone resulted in baseline macrophage inflammatory protein-1␤ production that was below the detectable threshold of the assay (data not shown).
For PAH patients, no correlation was observed between NK cell dysfunction and disease severity, as determined by hemodynamic parameters or 6-minute walk distance (data not shown). 
Decreased KIR Levels Are Not Associated With KIR or HLA Gene Polymorphisms
The KIR family of genes displays a high level of diversity at the allelic level, and extensive locus-specific polymorphic variability, as well. In the case of KIR3DL1, different polymorphic forms of the 3DL1 gene have been shown to result in distinct levels of NK cell surface expression. The most common of these polymorphisms have been categorized into forms that result in high (*001, *002, *0152, *020), low (*005, *007), and no (*004) surface expression. 19, 20 In addition to the many polymorphic forms of the inhibitory receptor, the 3DL1 locus can also encode an activating receptor, KIR3DS1.
To address the possibility that the decreased KIR3DL1 levels observed in our PAH patients were the result of a genetic predisposition in this group, a cohort of 222 British white PAH patients and 191 ethnicity-matched control subjects was typed for the KIR3DL1 and 3DS1 forms of the 3DL1 locus ( Figure 4A ). KIR3DL1-positive individuals were also typed for 7 of the most common polymorphic variants of KIR3DL1 ( Figure 4B ). This analysis failed to reveal any significant differences in the frequency of KIR3DL1, 3DS1, or any of the KIR3DL1 polymorphisms in PAH patients in comparison with controls.
The complex regulation of KIR surface expression is further compounded by the influence of HLA ligands, which can induce clonal expansion of NK cells expressing complementary KIR molecules and are themselves highly variable. The ligands for KIR3DL1 are HLA-B molecules and a few HLA-A types that contain the Bw4 motif. 21, 22 Bw4 allotypes containing isoleucine at position 80 (Bw480I) are preferential ligands over types with threonine at this position (Bw480T). 23, 24 KIR2DL1 and KIR2DS1 receptors bind the C2 form of the HLA-C molecule, whereas C1 allotypes are ligands for KIR2DL3 and weakly bind 2DL2. 25 The PAH and control cohorts were also genotyped for HLA-Bw6, HLA-Bw4 -80T, and Bw4 -80I ( Figure  4C) , and HLA-C1 and C2 ( Figure 4D ), as well. Again, no significant differences in allelic frequencies were found between the groups. Taken together, these results suggest that the observed differences in KIR surface expression on NK cells from PAH patients are not the direct result of a genetic predisposition, but may instead result from in vivo conditioning. 
TGF-␤ Regulates KIR Surface Expression
Considering the central role for the TGF-␤ superfamily in the pathogenesis of PAH, we questioned whether the impaired NK phenotype in PAH could be attributed to altered TGF-␤ signaling in these individuals. Treatment of freshly isolated NK cells from healthy donors with 10 ng/mL TGF-␤ induced a substantial drop in the surface expression of KIR3DL1 and KIR2DL1/S1, the 2 markers that were decreased in PAH ( Figure 5A ). In contrast, surface levels of KIR2DL2/3, which was unaltered in PAH patients, was relatively insensitive to TGF-␤ stimulation. A comparison of changes in KIR surface expression did not show greater reductions in KIRs following TGF-␤ stimulation in the patient group in comparison with controls (data not shown). However, this was likely due to the fact that NK cells from patients already exhibited depressed KIR expression at the time of isolation. In support of this, NK cells from PAH patients exhibited a marked recovery in KIR3DL1 levels after 72 hours ex vivo ( Figure 5B ). This recovery, which was not observed for any healthy control subjects or for KIR2DL1/S1 expression in either patients or controls, was blocked if TGF-␤ was added to the culture medium.
Gene expression of PAI-1 and uPA were used as downstream measures of TGF-␤ signaling in cultured NK cells. Cells from PAH patients demonstrated increased baseline expression of PAI-1 and uPA. A greater increase in PAI-1 gene expression was also observed in NK cells from PAH patients versus controls following stimulation with TGF-␤ ( Figure 5C ). No such effect was observed with uPA, for which gene expression was likely maximal in both groups following TGF-␤ stimulation. Together, these findings suggest that the impaired NK cell phenotype observed in PAH is the result of excessive TGF-␤ signaling. In agreement with previous reports investigating TGF-␤ signaling in pulmonary vascular smooth muscle cells from PAH patients, 3 division of the PAH cohort based on the presence or absence of a mutation in the gene for bone morphogenetic protein type II receptor revealed similarly increased of TGF-␤ signaling in both groups (online-only Data Supplement Figure I ).
Decreased NK Cell Number and Function in Rodent Models of PAH
To determine the relevance of these findings in vivo, we examined NK cell function in both the monocrotaline rat model and chronic hypoxic mouse model of PAH. Rats given monocrotaline developed pulmonary hypertension by 21 days after injection, as evidenced by elevated right ventricular systolic pressures and right ventricular hypertrophy ( Figure  6A and 6B) . In agreement with previous findings in the rat model, 2 monocrotaline-induced pulmonary hypertension was associated with increased TGF-␤ signaling, as demonstrated by increased PAI-1 gene expression in the lungs of monocrotaline-challenged rats ( Figure 6C ). Consistent with findings in human NK cell cultures, increased PAI-1 gene expression was accompanied by significantly decreased expression of rat kir3dl1 ( Figure 6D ). Analysis of peripheral blood and splenic lymphocytes demonstrated decreased numbers of NKR-P1A ϩ /CD3 Ϫ NK cells in both tissues for monocrotaline-treated animals ( Figure 6E and 6F) . In addition, splenic NK cells isolated from monocrotalinechallenged rats were functionally impaired, as demonstrated by a decreased capacity to lyse the YAC-1 murine lymphoma target cell line ( Figure 6G and online-only Data Supplement Figure II) .
Mice with chronic hypoxia-induced pulmonary hypertension also exhibited NK cell impairment. Mice maintained at 10% O 2 for 21 days developed significantly elevated right ventricular systolic pressures ( Figure 7A ) and right ventricular hypertrophy ( Figure 7B) , associated with increased pulmonary arteriolar muscularization ( Figure 7C through 7E) . Pulmonary hypertension was accompanied by decreased numbers of NKR-1.1 ϩ /CD3 Ϫ NK cells in the blood, spleen, and lungs of mice maintained under hypoxia ( Figure 7F and  7G) , and diminished NK cell function in response to stimulation with YAC-1 cells or interleukin 12, as well ( Figure  7H ). NK cells from hypoxia-exposed mice exhibited decreased degranulation in response to both stimuli, as mea-sured by the CD107a mobilization assay ( Figure 7I ). As in humans, naïve murine NK cells have a limited ability to produce interferon-␥ when cocultured with YAC-1 target cells. However, stimulation of NK cells with interleukin 12 revealed a decreased capacity of NK cells from hypoxic mice to secrete interferon-␥, further highlighting the reduced functional capacity of these cells ( Figure 7J ).
Increased Matrix Metalloproteinase Production in NK Cells From PAH Patients
Previous studies examining the mechanism by which dNK cells influence spiral artery remodeling in pregnancy suggested a role for matrix metalloproteinases (MMPs) in this process. 11, 26 Examination of MMP gene expression in ex vivo NK cell cultures revealed no significant difference in MMP-2 gene expression in PAH NK cells, but did show a significant increase in the expression of MMP-9 when compared with healthy donors (Figure 8A and 8B) . Quantification of active enzyme secretion in NK cell culture supernatants by gelatin zymography revealed no significant increase in active MMP-2, but did demonstrate increased levels of active MMP-9 in supernatants from PAH NK cell cultures ( Figure  8C ). High-molecular-weight forms of MMP-9 were also observed in 8 of the 12 patient samples, but none of the control samples. These high-molecular-weight bands have previously been identified as a complex of MMP-9 with neutrophil gelatinase-associated lipocalin, which has been shown to preserve MMP-9 activity by protecting the enzyme from degradation. 27 Further examination of extracellular matrix metalloproteinase inducer and tissue inhibitors of MMP (TIMP-1 and -3) gene expression revealed no significant differences between patients and controls (online-only Data Supplement Figure III ). However, a significant increase in TIMP-2 gene expression was observed in NK cells from PAH patients.
Discussion
Our findings identify for the first time an impairment of NK cell phenotype and function in human idiopathic and heritable PAH and 2 widely used animal models of the disease. In patients, this abnormal NK cell phenotype was marked by a rise in the functionally deficient CD56 Ϫ /CD16 ϩ subset. This change was not detected in a disease control group of CTEPH patients, suggesting that the observed NK dysfunction is specific to PAH and is not a secondary effect of altered pulmonary hemodynamics.
Beyond altered circulating subsets, NK cells from PAH patients also exhibited decreased surface levels of activating and inhibitory receptors, including a decrease in KIR3DL1 that we directly linked to impaired NK cytolytic function in these individuals. The observation of decreased KIR levels on NK cells from PAH patients differs from previous findings in HIV patients, in whom the functional deficiency of circulating NK cells was attributed to decreased levels of activating receptors and increased expression of inhibitory KIRs. 14 However, our findings are in agreement with a more recent model of NK cell education. 18 Under this model, increased expression of inhibitory receptors in the presence of the appropriate MHC-I ligand induces a dependence on inhibitory receptor-ligand interactions to maintain a resting state, accompanied by more robust cytotoxic responses when that inhibition is lacking, such as when an NK cell encounters an MHC-I-deficient target.
Previous studies investigating the role of KIRs in disease pathogenesis have primarily focused on the capacity of KIR and HLA gene polymorphism to influence receptor levels and alter NK cell function. Disease association studies have shown that KIR-HLA genotype interactions can influence the outcome of viral infections, including HIV. 28 Certain combinations of maternal KIR2D receptors and fetal HLA-C genes can also influence the risk of preeclampsia and dictate reproductive success. 12 In comparison, relatively little attention has been given to the possible role of in vivo conditioning in the regulation of KIR levels. Here we show that signaling through the TGF-␤ pathway, known to be perturbed in PAH, specifically downregulates disease-associated KIRs in vitro and contributes to the abnormal NK cell phenotype in patients. Previous studies in pulmonary arterial smooth muscle cells from PAH patients, with and without BMPR-II mutations, have highlighted altered responses to TGF-␤ stimulation. 3 In agreement with our current findings, increased TGF-␤ signaling has also been reported in the monocrotaline rat model of PAH, where it was specifically linked to increased TGF-␤ production by pulmonary artery smooth muscle cells and macrophages surrounding remodeled pulmonary arteries. 2 Inhibition of the type I TGF-␤ receptor, activin-like kinase 5, in this model attenuates and reverses the disease. In the context of NK cell function, TGF-␤ is has been shown to decrease surface expression of the activating receptors NKp30 and NKG2D and reduce cytotoxic activity. 29 There are also limited reports of the capacity of TGF-␤ to alter KIR expression on cultured NK cells. 30 However, our study is the first to demonstrate a role for TGF-␤ in the regulation of KIR expression in the context of a human disease.
As in PAH patients, our findings in the monocrotaline rat and chronic hypoxic mouse models of PAH demonstrate similar reductions in NK cell number, cytolytic activity, and cytokine production. These observations support a role for NK dysfunction in the pathogenesis of PAH and help address the limitation of examining NK cells from patients that are at different stages in disease progression and are receiving treatment with a range of therapies. In addition to reduced NK cell number and function, increased PAI-1 gene expression was also observed in the lungs of monocrotaline-challenged rats, consistent with increased TGF-␤ signaling. This increased PAI-1 expression was accompanied by decreased transcription of kir3dl1, the only KIR-like sequence that has been identified in the rat genome. 31 Despite the limited and ambiguous nature of the KIR repertoire in rodents, further support for a role of KIR3DL1 in PAH was provided by a recent study identifying kir3dl1 as one of a small number of genes that is significantly downregulated in the peripheral blood mononuclear cells of cattle that develop pulmonary hypertension at high altitude. 32 Having demonstrated an impairment of NK cell function in both human PAH and animal models of disease, the question remains as to how NK cell dysfunction may contribute to pathological vascular remodeling. During pregnancy, the extensive demuscularization of spiral arteries, coupled by a loss of the endothelial monolayer, represents a precise reversal of the vascular remodeling observed in the PAH lung. While the role of dNK cells in this process is now commonly accepted, the mechanism by which this remodeling is achieved remains uncertain. A recent report by Hanna and colleagues 8 suggested that secreted factors, including dNKderived angiogenic factors and chemokines, induce vascular remodeling and trophoblast migration. Other work using human tissues has implicated a role for dNK cell-derived MMPs in the induction of vascular cell apoptosis and the demuscularization of spiral arteries. 11, 26 Although dNK cells are thought to be a distinct subset to circulating NK cell populations, with a unique capacity to influence vascular structure, circulating NK cells have also been implicated in the support of collateral artery formation in a murine model of hindlimb ischemia 9 and in cardiac angiogenesis following myocardial infarction. 10 Our finding of increased MMP-9 gene expression and enzymatic activity in circulating NK cells from PAH patients provides a potential mechanism by which these cells can directly influence pathological pulmonary vascular remodeling. This finding is supported by previous work reporting elevated MMP-2 and MMP-9 in the lungs of rats with monocrotaline-induced pulmonary hypertension. 33 In addition to being a surrogate measure for enhanced TGF-␤ signaling, the identification of increased urokinase gene expression in NK cells from PAH patients also supports a role for these cells in the turnover of the extracellular matrix. In the monocrotaline rat model, it was suggested that MMPs allow for increased smooth muscle cell motility and the muscularization of the pulmonary arteries, as has been described previously for MMPs in the enhancement of tumor invasion and metastasis. 33 However, in pregnancy, MMP production is associated with the demuscularization of arteries and smooth muscle cell apoptosis, 11 suggesting that increased MMP production in NK cells from PAH patients may be a protective response to increased pulmonary vascular muscularization in the diseased lung.
Taken together, this study proposes a potentially important role for NK cells in the regulation of vascular remodeling beyond the context of pregnancy and provides novel insights into the complex mechanisms underlying PAH.
